Related Experiment Video
Updated: Jul 24, 2026

09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
28.9K
Voxel-Based Meta-Analysis of Gray Matter Abnormalities in Multiple System Atrophy
Junyu Lin1, Xinran Xu1, Yanbing Hou1
1Laboratory of Neurodegenerative Disorders, Department of Neurology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China.
Frontiers in Aging Neuroscience
|December 17, 2020
Summary
This meta-analysis reveals distinct brain atrophy patterns in multiple system atrophy subtypes. Cerebellum atrophy occurs in both parkinsonism (MSA-P) and cerebellar (MSA-C) types, while basal ganglia atrophy is specific to MSA-P.
Area of Science:
- Neuroimaging and Neuropathology
- Neurodegenerative Diseases
Background:
- Multiple system atrophy (MSA) is a progressive neurodegenerative disorder with two main clinical subtypes: parkinsonism (MSA-P) and cerebellar (MSA-C).
- Understanding the distinct neuropathological underpinnings of these subtypes is crucial for accurate diagnosis and targeted therapeutic strategies.
Approach:
- A systematic literature search was conducted across PubMed, Embase, and Web of Science for voxel-based morphometry (VBM) studies comparing MSA subtypes with healthy controls.
- Quantitative meta-analysis was performed using the Signed Differential Mapping (ES-SDM) method, with validation through Seed-based d Mapping with Permutation of Subject Images (SDM-PSI) and familywise error rate (FWE) correction.
Key Points:
- Both MSA-P and MSA-C subtypes exhibited cerebellar and cerebral cortex atrophy.
- Basal ganglia atrophy was uniquely identified in the MSA-P subtype.
- Specific cortical regions showed differential atrophy patterns between MSA-P and MSA-C, aligning with their clinical presentations.
Conclusions:
- The study identified distinct patterns of gray matter volume loss in MSA-P and MSA-C, supporting their classification as separate clinicopathological entities.
- These findings provide neuroimaging evidence for the differing pathophysiology underlying the clinical manifestations of MSA subtypes.
Related Concept Videos
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

